Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alternative tumour-specific antigens
Christof C. Smith, Sara R. Selitsky, Shengjie Chai, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 465-478
Open Access | Times Cited: 278

Showing 1-25 of 278 citing articles:

Therapeutic cancer vaccines
Mansi Saxena, Sjoerd H. van der Burg, Cornelis J.M. Melief, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 360-378
Closed Access | Times Cited: 1100
Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors
Lorenzo Galluzzi, Juliette Humeau, Aitziber Buqué, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 12, pp. 725-741
Closed Access | Times Cited: 1009
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fučíková, Oliver Kepp, Lenka Kašíková, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 749
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 476
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 454
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Daniel K. Wells, Marit M. van Buuren, Kristen K. Dang, et al.
Cell (2020) Vol. 183, Iss. 3, pp. 818-834.e13
Open Access | Times Cited: 407
Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang, Barbara Schrörs, Martin Löwer, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 4, pp. 261-282
Open Access | Times Cited: 341
Alternative splicing and cancer: a systematic review
Yuanjiao Zhang, Jinjun Qian, Chunyan Gu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 307
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 259
Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
Christian Flugel, Robbie G. Majzner, Giedre Krenciute, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 49-62
Open Access | Times Cited: 249
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 247
A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion
Devin Dersh, Jaroslav Hollý, Jonathan W. Yewdell
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 116-128
Closed Access | Times Cited: 213
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
Estelle Baulu, Célia Gardet, Nicolas Chuvin, et al.
Science Advances (2023) Vol. 9, Iss. 7
Open Access | Times Cited: 212
B Cell Function in the Tumor Microenvironment
Stephanie Downs‐Canner, Jeremy A. Meier, Benjamin G. Vincent, et al.
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 169-193
Open Access | Times Cited: 190
Exploring treatment options in cancer: Tumor treatment strategies
Beilei Liu, Hongyu Zhou, Licheng Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 186
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters, Huiming Xia, Katie M. Campbell, et al.
Genome Medicine (2019) Vol. 11, Iss. 1
Open Access | Times Cited: 177
Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire
Sebastian P. Haen, Markus Löffler, Hans‐Georg Rammensee, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 10, pp. 595-610
Open Access | Times Cited: 174
Identification of tumor antigens with immunopeptidomics
Chloé Chong, George Coukos, Michal Bassani‐Sternberg
Nature Biotechnology (2021) Vol. 40, Iss. 2, pp. 175-188
Closed Access | Times Cited: 151
Cancer immunotherapy: it’s time to better predict patients’ response
Charlotte Pilard, Marie Ancion, Philippe Delvenne, et al.
British Journal of Cancer (2021) Vol. 125, Iss. 7, pp. 927-938
Open Access | Times Cited: 127
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Lisa H. Butterfield, Yana G. Najjar
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 399-416
Closed Access | Times Cited: 100
Hallmarks of Resistance to Immune-Checkpoint Inhibitors
Maria Karasarides, Alexandria P. Cogdill, Paul B. Robbins, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 372-383
Open Access | Times Cited: 79
Rethinking Antigen Source: Cancer Vaccines Based on Whole Tumor Cell/tissue Lysate or Whole Tumor Cell
Lu Diao, Mi Liu
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 70
Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements
Marianne Burbage, Ares Rocañín-Arjó, Blandine Baudon, et al.
Science Immunology (2023) Vol. 8, Iss. 80
Closed Access | Times Cited: 65
Activation of human endogenous retroviruses and its physiological consequences
Nicholas Dopkins, Douglas F. Nixon
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 3, pp. 212-222
Closed Access | Times Cited: 57
Peptide-based vaccine for cancer therapies
Luigi Buonaguro, Maria Tagliamonte
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top